Sign in
Taking people in United StatesNo phase

Checking childhood cancer survivors at risk for sensory problems

Tests a record-based alert to prompt sensory screening in childhood cancer survivors.

Key facts

Who runs it
Washington University School of Medicine
Where
St Louis, United StatesSee the site
Trial code
Registry title
Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors
Status
Recruiting
People taking part
146 people, planned
Started
2 Aug 2023
Expected to end
31 May 2027
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Highlighting Patients at Risk for Sensory Screening (HPARSS)
Record updated
15 June 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for children and teens who had cancer and finished treatment 6 months to 2 years ago. It tests a tool that flags who needs hearing and vision screening.

Age
7 to 17 years old
Sex
All sexes can join.
Disease stage
Cancer diagnosed before age 18, with all cancer treatment finished.
Earlier treatment
Must have had chemotherapy and/or radiation therapy. All cancer therapy must have ended at least 6 months and less than 2 years ago.

Main reasons for not taking part

  • Currently in active cancer treatment
  • In the care of the Late Effects Program at St. Louis Children's Hospital
  • Already had diagnostic testing or rehabilitative therapy for a deficit that screening covers
  • No contact with the treatment team in the past two years
  • In foster care or without a legal guardian

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Patients with a diagnosis of pediatric cancer (diagnosis at <18 years of age)
  • Treatment including chemotherapy and/or radiation therapy
  • Completion of all cancer therapy for at least 6 months and less than 2 years
  • Followed in the Division of Pediatric Hematology/Oncology Program at the Washington University School of Medicine
  • Current age between 7 and 17 years of age (age where all of the screening tests are both valid and have been successfully performed by our group)
  • English speaking

Who cannot take part

  • Received previous diagnostic testing or rehabilitative therapy for a secondary deficit eligible for screening
  • Undergoing active cancer treatment
  • Patient under the care of the Late Effects Program at St. Louis Children's Hospital
  • Parents and/or patient illiteracy
  • No contact with treatment team in the past two years
  • In foster care or without a legal guardian

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 7 and 17 years old?

Where in United States

  • St. Louis Children's Hospital - Washington University School of MedicineSt Louis, United StatesContact: Robert J Hayashi, M.D.Taking people

About the trial

What the trial wants to find out

The overall goal of this study is to attempt to overcome the organizational barriers that impede prompt screening for at-risk sensory deficits in childhood cancer survivors (CCS). Using a cross sectional design study, collaborators in the Informatics Research branch of the Institute of Informatics at the Washington University School of Medicine will identify CCS at risk for sensory deficits based upon their therapy exposure to generate the highlighting patients at risk for sensory screening (HPARSS) document. The investigators will utilize the HPARSS that will link therapy related risks for sensory deficits to specific screening procedures prompting the primary oncology provider to implement screening, diagnostic testing, and therapy.

The 2 groups in the trial

  • Patients: Highlighting Patients at Risk for Sensory Screening (HPARSS)Treatment being tested

    * The primary oncology team will utilize the HPARSS to identify patients who are at risk for sensory deficits based on prior treatment. The HPARSS will constitute a file of that will contain eligible patients based upon their past treatment and their corresponding risk for a particular sensory deficit based upon that treatment. The patient and parent/guardian will be approached to participate in the study. * Sensory deficit screening will be completed in the clinic and any screening results that indicate the need for referral for diagnostic testing or therapy will be scheduled by the primary treatment team staff.

    Treatment: Highlighting Patients at Risk for Sensory Screening (HPARSS)

  • Providers: Highlighting Patients at Risk for Sensory Screening (HPARSS)No study treatment, for comparison

    -Providers will complete a survey regarding their views of the HPARSS. The Acceptability of Intervention Measure has 4 questions and the Feasibility of Intervention Measure has 4 questions.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Highlighting Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors
Plain-language title
Checking childhood cancer survivors at risk for sensory problemsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT05582551, who can take part
Record updated
15 June 2026